Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Shares Issued (2018 - 2025)

Sutro Biopharma's Shares Issued history spans 7 years, with the latest figure at $69.7 million for Q4 2024.

  • For Q4 2024, Shares Issued changed N/A year-over-year to $69.7 million; the TTM value through Sep 2025 reached $69.7 million, up 3670.51%, while the annual FY2024 figure was $71.5 million, 22679.3% up from the prior year.
  • Shares Issued for Q4 2024 was $69.7 million at Sutro Biopharma, up from $937000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $250.1 million in Q4 2020 and bottomed at -$96.8 million in Q3 2020.
  • The 5-year median for Shares Issued is $937000.0 (2024), against an average of $22.5 million.
  • The largest YoY upside for Shares Issued was 532091.49% in 2020 against a maximum downside of 17883.83% in 2020.
  • A 5-year view of Shares Issued shows it stood at $250.1 million in 2020, then tumbled by 99.79% to $513000.0 in 2021, then soared by 10554.39% to $54.7 million in 2022, then crashed by 119.41% to -$10.6 million in 2023, then soared by 756.79% to $69.7 million in 2024.
  • Per Business Quant, the three most recent readings for STRO's Shares Issued are $69.7 million (Q4 2024), $937000.0 (Q3 2024), and $794000.0 (Q2 2024).